Expert Answer
Quick Answer
No. NMN raises NAD+, but no human trial shows it reverses aging, and consensus across the five experts is just 2.3/5. Attia files NAD under "noise" and notes the ITP program found NR failed to extend lifespan in mice. Huberman takes NMN but says it's for energy, not longevity. Only Hyman fully endorses it.
Split Consensus
on NMN / NAD+ overall
Files NAD precursors under "noise" on his evidence hierarchy, and notes the ITP program found nicotinamide riboside failed to extend lifespan, with little evidence of efficacy in humans.
Personally takes NR and NMN, but is explicit it's for subjective energy, not longevity, and says sleep, exercise, and nutrition far outweigh any supplement.
The most balanced take: promising in rodents but unproven in humans, with oral doses largely metabolized to nicotinamide before reaching tissues; more clinical research is needed.
The lone advocate; recommends NAD precursors as part of a longevity stack, framing NAD as essential for mitochondria and DNA repair.
Notably absent: the most data-obsessed self-experimenter does not include NMN or NAD precursors in his Blueprint stack.
NMN is one of the most hyped, and most divisive, longevity supplements, scoring just 2.3/5 across the five experts. The marketing promises to reverse aging; the experts who actually study it don't agree. Four of five are skeptical, cautious, or silent, and only Mark Hyman is a full advocate.
Peter Attia files NAD boosters under "noise" on his evidence hierarchy, below rapamycin and metformin. His reason: the Interventions Testing Program, the gold-standard mouse-longevity program, found nicotinamide riboside failed to extend lifespan, and there's little evidence of efficacy in humans.
Andrew Huberman personally takes NR and NMN daily, but is explicit that it's for subjective energy, not longevity, and he's clear that sleep, exercise, and nutrition far outweigh any supplement. Rhonda Patrick gives the most thorough scientific take: NMN and NR are promising in rodents, but human data is limited, oral doses are largely broken down to nicotinamide before reaching most tissues, and more clinical research is needed before calling it safe and effective for longevity.
The "reverse aging" framing traces largely to David Sinclair, a guest on these shows rather than one of the consensus experts. Bryan Johnson, the most data-obsessed self-experimenter, doesn't include NMN in his Blueprint stack at all. The cheaper, better-evidenced way to raise NAD+, per both Patrick and Attia: exercise and fasting. For the NMN-versus-NR form question, see our dedicated comparison.
No. Attia notes the Interventions Testing Program, which tests whether compounds extend lifespan in genetically diverse mice, found nicotinamide riboside failed to extend lifespan.
On his proven-to-noise scale, he ranks NAD precursors "noise" because of the ITP lifespan failure and little evidence of efficacy in humans.
Yes, oral NR and NMN raise blood NAD+. But Patrick notes metabolic improvements were inconsistent, and oral doses are largely metabolized to nicotinamide before reaching most tissues. Raising NAD+ is not the same as reversing aging.
Mostly from David Sinclair, a guest on Huberman, Attia, and Patrick episodes, not one of the five consensus experts. The hosts who interviewed him stayed skeptical or personal-use-only.
Exercise and fasting, which raise NAD+ naturally (Patrick, Attia), plus VO2 max and strength, which Attia and Huberman rank far above any supplement.
This page covers what researchers agree on. Pro gives you the specific dosages, timing schedules, and interaction warnings they each recommend — with video citations you can verify.
Cancel anytime
Full NMN / NAD+ Consensus Report
See what all the experts agree and disagree on